// App-Quantinova.ai

: Evaluation of ctDNA in patients with CRPC with pathogenic germline mutations in BRCA2.

Researchers

Presenter

  • Minqi Huang

Principal Investigators

  • Ellen B. Jaeger

  • Sydney Caputo

  • Crystal Casado

  • Albert Jang

  • Patrick L Sweeney

  • Sree M Lanka

  • Kanika Gupta

  • Alexandra Lieberman

  • Jennifer Schwartz

  • Olivia Pocha

  • Maddie Hawkins

  • Patrick Miller

  • Jodi Lyn Layton

  • Brian E. Lewis

  • Pedro C. Barata

  • Elisa M. Ledet

  • A. Oliver Sartor

Medical Centers

  • Department of Dermatology, University Hospitals Case Medical Center, Cleveland, OH

  • Tulane University School of Medicine, New Orleans, LA

Locations

  • United States

Companies

  • Tempus Labs Inc.

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Breast cancer type 2 susceptibility protein

  • Circulating DNA

Drug/Treatment

  • Enzalutamide

  • CB-7598

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved